9Schadeorf D, Diehl S,Zuberbier T, et al.Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage[J].Dermatology, 1996,192 (2): 89.
6[1]Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosomellp11.2 [J].Science, 1995,268(5212) :884-886.
7[4]Ueda T, Ichikawa T, Tamaru J, et al. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer[J]. Am J Pathol,1996,149(5): 1435-1440.
8[6]Hemler ME, Mannion BA, Berditchevski F. Association of TM4SF proteins with integrins: relevance to cancer [J]. Biochim Biophys Acta,1996,1287(2-3) :67-71.
9[7]Mannion BA, Berditchevski F, Kraeft SK, et al. Transmembrane 4 superfamily proteins CD81 (TAPA- 1 ), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 ( CD49d/ CD 29) [J]. J Immunol, 1996,157(5) :2039-2047.
10[8]Rubinstein E, Le Naour F , Lagaudriere-Gesbert C, et al . CD9, CD63,CD81 ,and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins[J]. Eur J Immunol, 1996,26(11): 2657-2665.
3Gupta GP,MassaguéJ.Platelets and metastasis revisited:anovel fatty link[J].J Clin Invest,2004,114(12):1691-1693.
4Dardik R,Savion N,Kaufmann Y,et al.Thrombin promotes plalelet-mediated melanoma cell adhesion to tndothelial cells under flow conditions:role of platelet glycoproteins P-selectin and GP Ⅱ b-Ⅲ A[J].Br J Cancer,1998,77(12):2069-2075.
5Leo R,Pratico D,Iuliano L,et al.Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and than reoxygenated[J].Circulation,1997,95(4):885-891.
6Medina C,Jurasz P,Santos-Martinez MJ,et al.Platelet aggregation-induced by caco-2 cells:regulation by matrix metalloproteinase-2 and adenosine diphosphate[J].J Pharmacol Exp Ther,2006,317(2):739-745.
7Borsig L.The role of platelet activation in tumor metastasis[J].Expert Rev Anticancer Ther,2008,8(8):1247-1255.
